Re: Not good for the potential of apabetalone as a Covid-19 therapy
in response to
by
posted on
Dec 01, 2021 04:59PM
"I return to my earlier disgust over trial design - when it became clear that they had not designed the study to even evaluate benefits against long covid, where apabetalone seemed most likely to shine." (imtesty)
I agree wholeheartedly with that statement..bang on...Long Covid